SAN DIEGO –Illumina, Inc. (NASDAQ: ILMN) has committed US $60 million in sequencing capabilities to a global pathogen genomics initiative, in partnership with the Bill & Melinda Gates Foundation and other public and private entities. The initiative expands on the Africa Pathogen Genomics Initiative (Africa PGI) announced in October 2020, and will help create a […]

SOUTH SAN FRANCISCO, Calif. & FRANKFURT — Twist Bioscience Corporation (Nasdaq: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, and Vivlion GmbH, a company providing next-generation CRISPR gRNA libraries and screening services for the global R&D market, today announced a collaboration for the generation of […]

Shoreline Biome’s microbiome products now available in Germany, Austria and Switzerland. FARMINGTON, Conn.— Shoreline Biome, a microbiome research company that develops complete solutions for characterizing microbiome populations down to the strain level, has entered into an exclusive distribution partnership with BioCat GmbH, a leading provider of life sciences solutions, for the promotion, sale and support […]

MENLO PARK, Calif. — Pacific Biosciences of California, Inc. (Nasdaq: PACB), a leading provider of high-quality, long-read sequencing platforms, announced today that Dr. Hannah Valantine has been nominated for election to the Company’s Board of Directors as a Class II director at the Company’s 2021 Annual Meeting of Stockholders. Dr. Valantine is currently a Professor […]

Company will receive up to $5 Million in grant funds from DARPA as part of the agency’s Nucleic Acids On-Demand World-Wide Program to plan for and prevent the next viral pandemic SAN FRANCISCO and PARIS — DNA Script today announced a partnership with Moderna, Inc. (Nasdaq: MRNA) to develop a prototype for rapid mobile manufacturing of […]

Company Plans Commercial Operations in 2021 MURRIETA, Calif. — Murrieta Genomics, the launch pad for genomic sequencing startups, has announced that simplSEQ, an incubator company, has completed its seed round funding, having received $2 million in total. Funds are to be used to validate the company’s novel sample preparation technology with external labs, further protect its patent-pending intellectual property and […]

HiFi Sequencing and Software v10.1 Release on the Sequel II and IIe Systems Increases Scalability, Improves Usability, and Unlocks Additional Sample Types to Extend the Value of HiFi Reads MENLO PARK, Calif. — Pacific Biosciences of California, Inc. (Nasdaq: PACB), a global leader offering a comprehensive view of genomes, transcriptomes, and epigenomes, today announced the availability of […]

Centrillion’s sequencing chips for high throughput SARS-CoV-2 variant detection are faster and more accurate than other methods PALO ALTO, CA, UNITED STATES — Centrillion Technologies, an innovator in DNA chip technologies, is announcing the world-wide availability of its VirusHunter™ QuadCore chips for SARS-CoV-2 whole genome sequencing and multi-pathogen detection. The chip set contains probes for sequencing […]

Collaboration is essential for innovation to thrive. At Genestack we help life-science organizations generate insights and value from their multi-omics data through FAIR (and beyond) data management and collaboration. The Pistoia Alliance is a global, not-for-profit organization that lowers barriers to R&D innovation by providing a legal framework to enable straightforward and secure pre-competitive collaboration […]

SAN DIEGO–Illumina, Inc. (NASDAQ: ILMN) and Kartos Therapeutics, Inc. are pleased to announce a new partnership to co-develop a TP53 companion diagnostic (CDx) based on the content of Illumina’s comprehensive genomic profiling assay, TruSight™ Oncology 500 (TSO 500). This companion diagnostic for multiple hematologic indications will be the first to use TSO 500 with peripheral […]